ConductScience.org, home

Paper · 41547660

​Construction of a novel AIE NIR fluorescence probe for monitoring lipid droplet dynamics during drug intervention and identification of disease models.

Wang Y and 7 others. Mikrochim Acta, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. ​Construction of a novel AIE NIR fluorescence probe for monitoring lipid droplet dynamics during drug intervention and identification of disease models. Papers, record 41547660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41547660

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
​Construction of a novel AIE NIR fluorescence probe for monitoring lipid droplet dynamics during drug intervention and identification of disease models.
PubMed
Journal
Mikrochim Acta
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYuqing
2Wang ZZhiyu
3Yu KKun
4Yang JJing
5Su QQi
6Wang JJie
7Hu LLei
8Wang HHui

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fluorescent DyesMajor topic
Lipid DropletsMajor topic
Humans
Animals
Fluorescent Chemosensor Compounds
Mice
Infrared Rays
Ferroptosis
Optical Imaging

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023AH010073Excellent Sci-tech Innovation Teams of Universities in Anhui ProvincePubMed
2023AH051747,2023AH051762Natural Science Foundation of Anhui Higher Education Institutions of ChinaPubMed
S202410368090Anhui university students innovation and entrepreneurship education training programPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,225,859The Relationship Between Ferroptosis and Diseases.J Multidiscip Healthc2022https://conductscience.org/library/papers/36225859PubMed
234,944,707Lipid Droplets, Phospholipase A2, Arachidonic Acid, and Atherosclerosis.Biomedicines2021https://conductscience.org/library/papers/34944707PubMed
332,814,328Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.Neurodegener Dis2020https://conductscience.org/library/papers/32814328PubMed
436,415,176Lipid droplets as the genetic nexus of fatty liver.Liver Int2022https://conductscience.org/library/papers/36415176PubMed
536,048,423Schiff Base Aggregation-Induced Emission Luminogens for Sensing Applications: A Review.ACS Sens2022https://conductscience.org/library/papers/36048423PubMed
637,734,229Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.Redox Biol2023https://conductscience.org/library/papers/37734229PubMed
734,445,723Target of Rapamycin Complex 1 (TORC1), Protein Kinase A (PKA) and Cytosolic pH Regulate a Transcriptional Circuit for Lipid Droplet Formation.Int J Mol Sci2021https://conductscience.org/library/papers/34445723PubMed
839,588,271Molecular mechanisms of lipid droplets-mitochondria coupling in obesity and metabolic syndrome: insights and pharmacological implications.Front Physiol2024https://conductscience.org/library/papers/39588271PubMed
938,241,915Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis.Phytomedicine2024https://conductscience.org/library/papers/38241915PubMed
1032,714,562Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome.NPJ Aging Mech Dis2020https://conductscience.org/library/papers/32714562PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41547660

GET https://conductscience.org/api/papers/v1/41547660/references?page=2